This is an infection caused by bacteria from a specific family called Fusobacteriaceae. These bacteria are part of a larger group called Fusobacterales. Think of it like a specific type of germ causing an illness.
Every report comes from a Lived member, sent anonymously.
Have you tried Flagyl (Metronidazole) for Fusobacteriaceae Infections?
Fusobacteriaceae infections are infections caused by bacteria from the Fusobacteriaceae family. In people, nearly all of them involve species of Fusobacterium, most often Fusobacterium necrophorum and Fusobacterium nucleatum. These are anaerobic bacteria, meaning they grow without oxygen. They normally live harmlessly in the mouth, the gut and the female genital tract, but when they get into deeper tissue they tend to form abscesses (pockets of pus) and can spread into the bloodstream. The infections fall into a few broad patterns. In teenagers and young adults who are otherwise healthy, F. necrophorum causes throat infections, abscesses beside the tonsils, ear and mastoid infections and sinus infections. The best-known complication is Lemierre syndrome: an infected blood clot forms in the internal jugular vein, the large vein running down the side of the neck, and pieces of infected material travel to the lungs and sometimes elsewhere. In older adults, often people with cancer or other serious illness, F. nucleatum more often causes bloodstream infection, frequently from the abdomen or with no obvious starting point. Fusobacteria can also cause abscesses in the liver, brain, skin and pelvis. These infections are uncommon, but they can be serious, which is why recognizing them early matters.
Because these bacteria already live in the body, infection usually starts when they get past the lining of the throat, gums, ear, sinuses or gut into tissue where they can multiply. A throat infection, dental or gum disease, an ear infection or a problem in the abdomen such as appendicitis can provide that opening. Who is affected depends on the species. F. necrophorum throat infections are most strongly linked to ages 15 to 30, and serious ear infections with this organism are most often complicated in children under 2. Bloodstream infection with F. nucleatum is more common in older adults and in people with cancer (particularly blood cancers), kidney failure treated with dialysis or other long-term illness. A severe gum infection called necrotizing ulcerative gingivitis, in which fusobacteria play a part, is linked to HIV, malnutrition, poor oral hygiene, alcohol and tobacco use. Carrying these bacteria is not the same as being infected. F. necrophorum can be found in the throats of up to 1 in 5 healthy adults, so finding it on a swab does not by itself prove it caused a sore throat.
Diagnosis starts with recognizing that an infection is more than an ordinary sore throat or ear infection. Clues include severe or persistent symptoms, swelling or tenderness along one side of the neck, trouble opening the mouth, or high fevers. About half of people later found to have Lemierre syndrome have a normal examination when first seen, so clinicians rely partly on how the illness is behaving over time. Confirming the organism usually means growing it in the laboratory from blood cultures (including bottles designed for anaerobic bacteria) or from pus drained from an abscess. Fusobacteria grow slowly and can be missed, especially if antibiotics were started before samples were taken. Molecular tests that detect bacterial DNA can improve detection but are not routinely available everywhere. Standard rapid strep tests and routine sore throat testing do not look for fusobacteria. Imaging shows where the infection has spread. For suspected Lemierre syndrome, a contrast CT or MRI scan of the neck looks for a clot in the jugular vein and for abscesses, and chest imaging looks for infected spots in the lungs. A brain MRI, ear and skull imaging or liver imaging may be added depending on symptoms. Lemierre syndrome is diagnosed when a throat infection, fusobacteria (or a similar organism), spread to a distant site and a clot in the jugular vein come together, although some cases never grow an organism.
Antibiotics are the core of treatment, and serious infections are usually treated in the hospital with intravenous (IV) antibiotics. Because labs often cannot test which antibiotics a particular strain responds to, doctors start with broad options that reliably work against fusobacteria and other bacteria that may be present. Common choices are a penicillin-type antibiotic combined with a beta-lactamase inhibitor (an ingredient that stops some bacteria from breaking the antibiotic down), a carbapenem (a very broad hospital antibiotic), or ceftriaxone (a cephalosporin antibiotic) together with metronidazole (an antibiotic aimed at anaerobic bacteria). Resistance to clindamycin and moxifloxacin has been increasing, so they are generally not relied on before lab results are available. Once the organism and its sensitivities are known, treatment may be narrowed, sometimes to penicillin. Milder ear, nose and throat infections may be treated with a penicillin-type antibiotic plus metronidazole, by IV or by mouth. Treatment is long. Bloodstream infections are commonly treated for 2 to 6 weeks, abscesses for more than 2 weeks, and Lemierre syndrome for 3 to 6 weeks, because the infection sits inside a vein. These durations come from case series, since no clinical trials have compared regimens. Drainage is often as important as antibiotics. Abscesses in the neck, liver, brain or elsewhere may need to be drained with a needle or surgery, and children with serious ear infections from F. necrophorum frequently need mastoid surgery. For Lemierre syndrome, doctors may also prescribe a blood thinner (anticoagulant) to stop the clot from growing or shedding. This is increasingly common, especially when the clot is large or extends toward the brain, but studies have not proven that it improves outcomes, so the decision weighs the extent of the clot against the person's bleeding risk.
A serious Fusobacterium infection usually means several days or more in the hospital, followed by weeks of antibiotics. Fevers can take time to settle. In Lemierre syndrome, new infected spots appear in about 1 in 8 people even after effective antibiotics have started, so the care team may repeat scans and some people need a further drainage procedure. That does not necessarily mean treatment has failed. With prompt treatment, most people recover. In one large review of published Lemierre cases, about 4 in 100 people died, although other modern reports describe higher rates. Bloodstream infections carry more risk, with roughly 1 in 8 people dying within a month in one series. The risk is driven mainly by underlying illness, and it is lower in younger, otherwise healthy people with F. necrophorum. A jugular vein clot may still be visible on scans months later without causing ongoing problems. Follow-up focuses on completing the full antibiotic course, checking that abscesses have resolved and, if a blood thinner was prescribed, deciding with the care team when to stop it. For bloodstream infections with no obvious source, doctors may look for an underlying problem in the abdomen or elsewhere. Researchers have also found F. nucleatum in some colorectal cancers. This is an area of active study and is separate from the acute infections described here.
Contact your care team if a sore throat or ear infection lasts longer than expected, is unusually severe, or improves and then gets worse. Get seen the same day if a sore throat is followed by pain or swelling on one side of the neck, high fever with shaking chills, or difficulty opening your mouth. Mention Lemierre syndrome if you are concerned, since it is easy to overlook early. If you are already being treated, let the team know promptly about new pain in a joint, the chest or the belly, a new severe headache, or fever that returns. Seek emergency care for signs of sepsis, a life-threatening reaction to infection: confusion, fast breathing or shortness of breath, a racing heart, cold and clammy skin, or extreme pain.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fusobacteriaceae Infections is like, what's helped you, or ask the community a question.